Matches in SemOpenAlex for { <https://semopenalex.org/work/W3010149085> ?p ?o ?g. }
- W3010149085 endingPage "111" @default.
- W3010149085 startingPage "107" @default.
- W3010149085 abstract "Objective: To analyze the clinical characteristics of cases of novel coronavirus pneumonia and a preliminary study to explore the relationship between different clinical classification and liver damage. Methods: Consecutively confirmed novel coronavirus infection cases admitted to seven designated hospitals during January 23, 2020 to February 8, 2020 were included. Clinical classification (mild, moderate, severe, and critical) was carried out according to the diagnosis and treatment program of novel coronavirus pneumonia (Trial Fifth Edition) issued by the National Health Commission. The research data were analyzed using SPSS19.0 statistical software. Quantitative data were expressed as median (interquartile range), and qualitative data were expressed as frequency and rate. Results: 32 confirmed cases that met the inclusion criteria were included. 28 cases were of mild or moderate type (87.50%), and four cases (12.50%) of severe or critical type. Four cases (12.5%) were combined with one underlying disease (bronchial asthma, coronary heart disease, malignant tumor, chronic kidney disease), and one case (3.13%) was simultaneously combined with high blood pressure and malignant tumor. The results of laboratory examination showed that the alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin (ALB), and total bilirubin (TBil) for entire cohort were 26.98 (16.88 ~ 46.09) U/L and 24.75 (18.71 ~ 31.79) U/L, 39.00 (36.20 ~ 44.20) g/L and 16.40 (11.34 ~ 21.15) μmol/L, respectively. ALT, AST, ALB and TBil of the mild or moderate subgroups were 22.75 (16.31 ~ 37.25) U/L, 23.63 (18.71 ~ 26.50) U/L, 39.70 (36.50 ~ 46.10) g/L, and 15.95 (11.34 ~ 20.83) μmol/L, respectively. ALT, AST, ALB and TBil of the severe or critical subgroups were 60.25 (40.88 ~ 68.90) U/L, 37.00 (20.88 ~ 64.45) U/L, 35.75 (28.68 ~ 42.00) g/L, and 20.50 (11.28 ~ 25.00) μmol/L, respectively. Conclusion: The results of this multicenter retrospective study suggests that novel coronavirus pneumonia combined with liver damage is more likely to be caused by adverse drug reactions and systemic inflammation in severe patients receiving medical treatment. Therefore, liver function monitoring and evaluation should be strengthened during the treatment of such patients." @default.
- W3010149085 created "2020-03-13" @default.
- W3010149085 creator A5000972679 @default.
- W3010149085 creator A5001869015 @default.
- W3010149085 creator A5003642180 @default.
- W3010149085 creator A5008579080 @default.
- W3010149085 creator A5009045546 @default.
- W3010149085 creator A5010398730 @default.
- W3010149085 creator A5011593345 @default.
- W3010149085 creator A5013688157 @default.
- W3010149085 creator A5015640756 @default.
- W3010149085 creator A5016649545 @default.
- W3010149085 creator A5023302530 @default.
- W3010149085 creator A5030712229 @default.
- W3010149085 creator A5042802750 @default.
- W3010149085 creator A5043430232 @default.
- W3010149085 creator A5053122964 @default.
- W3010149085 creator A5070262652 @default.
- W3010149085 creator A5070779625 @default.
- W3010149085 creator A5071752182 @default.
- W3010149085 creator A5073101829 @default.
- W3010149085 creator A5079974353 @default.
- W3010149085 creator A5088585973 @default.
- W3010149085 creator A5090748802 @default.
- W3010149085 creator A5091719802 @default.
- W3010149085 date "2020-02-20" @default.
- W3010149085 modified "2023-10-12" @default.
- W3010149085 title "[Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study]" @default.
- W3010149085 doi "https://doi.org/10.3760/cma.j.issn.1007-3418.2020.02.003" @default.
- W3010149085 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32077660" @default.
- W3010149085 hasPublicationYear "2020" @default.
- W3010149085 type Work @default.
- W3010149085 sameAs 3010149085 @default.
- W3010149085 citedByCount "53" @default.
- W3010149085 countsByYear W30101490852020 @default.
- W3010149085 countsByYear W30101490852021 @default.
- W3010149085 countsByYear W30101490852022 @default.
- W3010149085 countsByYear W30101490852023 @default.
- W3010149085 crossrefType "journal-article" @default.
- W3010149085 hasAuthorship W3010149085A5000972679 @default.
- W3010149085 hasAuthorship W3010149085A5001869015 @default.
- W3010149085 hasAuthorship W3010149085A5003642180 @default.
- W3010149085 hasAuthorship W3010149085A5008579080 @default.
- W3010149085 hasAuthorship W3010149085A5009045546 @default.
- W3010149085 hasAuthorship W3010149085A5010398730 @default.
- W3010149085 hasAuthorship W3010149085A5011593345 @default.
- W3010149085 hasAuthorship W3010149085A5013688157 @default.
- W3010149085 hasAuthorship W3010149085A5015640756 @default.
- W3010149085 hasAuthorship W3010149085A5016649545 @default.
- W3010149085 hasAuthorship W3010149085A5023302530 @default.
- W3010149085 hasAuthorship W3010149085A5030712229 @default.
- W3010149085 hasAuthorship W3010149085A5042802750 @default.
- W3010149085 hasAuthorship W3010149085A5043430232 @default.
- W3010149085 hasAuthorship W3010149085A5053122964 @default.
- W3010149085 hasAuthorship W3010149085A5070262652 @default.
- W3010149085 hasAuthorship W3010149085A5070779625 @default.
- W3010149085 hasAuthorship W3010149085A5071752182 @default.
- W3010149085 hasAuthorship W3010149085A5073101829 @default.
- W3010149085 hasAuthorship W3010149085A5079974353 @default.
- W3010149085 hasAuthorship W3010149085A5088585973 @default.
- W3010149085 hasAuthorship W3010149085A5090748802 @default.
- W3010149085 hasAuthorship W3010149085A5091719802 @default.
- W3010149085 hasConcept C119060515 @default.
- W3010149085 hasConcept C126322002 @default.
- W3010149085 hasConcept C159641895 @default.
- W3010149085 hasConcept C2777513400 @default.
- W3010149085 hasConcept C2777914695 @default.
- W3010149085 hasConcept C2992208098 @default.
- W3010149085 hasConcept C71924100 @default.
- W3010149085 hasConcept C90924648 @default.
- W3010149085 hasConceptScore W3010149085C119060515 @default.
- W3010149085 hasConceptScore W3010149085C126322002 @default.
- W3010149085 hasConceptScore W3010149085C159641895 @default.
- W3010149085 hasConceptScore W3010149085C2777513400 @default.
- W3010149085 hasConceptScore W3010149085C2777914695 @default.
- W3010149085 hasConceptScore W3010149085C2992208098 @default.
- W3010149085 hasConceptScore W3010149085C71924100 @default.
- W3010149085 hasConceptScore W3010149085C90924648 @default.
- W3010149085 hasIssue "2" @default.
- W3010149085 hasLocation W30101490851 @default.
- W3010149085 hasOpenAccess W3010149085 @default.
- W3010149085 hasPrimaryLocation W30101490851 @default.
- W3010149085 hasRelatedWork W2090258227 @default.
- W3010149085 hasRelatedWork W2167384912 @default.
- W3010149085 hasRelatedWork W3001118548 @default.
- W3010149085 hasRelatedWork W3001897055 @default.
- W3010149085 hasRelatedWork W3002108456 @default.
- W3010149085 hasRelatedWork W3004318991 @default.
- W3010149085 hasRelatedWork W3007114958 @default.
- W3010149085 hasRelatedWork W3007189521 @default.
- W3010149085 hasRelatedWork W3007273493 @default.
- W3010149085 hasRelatedWork W3007814559 @default.
- W3010149085 hasRelatedWork W3007940623 @default.
- W3010149085 hasRelatedWork W3008090866 @default.
- W3010149085 hasRelatedWork W3008827533 @default.
- W3010149085 hasRelatedWork W3009885589 @default.
- W3010149085 hasRelatedWork W3010637630 @default.
- W3010149085 hasRelatedWork W3012849736 @default.